Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1058 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-01-17 (newstarget.com)
Dr. Bryan Ardis BLOWS THE WHISTLE on COVID-19 and CLOT SHOTS attacking the body like snake venom and he speaks on detoxification and prevention of damage
Dr. Bryan Ardis, with his Global Healings Team, has identified natural remedies to protect against the effects of COVID-19 and “clot shot” spike protein injections. The team, drawing from indigenous medicine and global natural resources, has sourced plants and minerals that can detoxify and protect against foreign particles and prions. Some recommended remedies include organic […]
Read more
2024-03-02 (focus.ua)
"Deadly" farm: the US fears a new pandemic because of 30,000 monkeys
They want to sell the animals to universities and pharmaceutical companies to test drugs and study the effects of infectious diseases. Animal rights activists and activists are outraged: the former protect primates, and...
Read more
2023-09-13 (nature.com)
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
The zoonotic Rift Valley fever virus (RVFV) can cause severe disease in humans and has pandemic potential, yet no approved vaccine or therapy exists. Here we describe a dual-mechanism human monoclonal antibody (mAb) combination against RVFV that is effective at minimal doses in a lethal mouse model of infection. We structurally analyze and characterize the binding mode of a prototypical potent Gn domain-A-binding antibody that blocks attachment and of an antibody that inhibits infection by abrogating the fusion process as previously determined. Surprisingly, the Gn domain-A antibody does not directly block RVFV Gn interaction with the host receptor low density lipoprotein receptor-related protein 1 (LRP1) as determined by a competitive assay. This study identifies a rationally designed combination of human mAbs deserving of future investigation for use in humans against RVFV infection.
Read more
2023-07-04 (investorplace.com)
3 Cheap Stocks to Buy Before They Bounce Back
Afraid of missing out on the big market rally? These three cheap stocks to buy are still strong options, so hop on board.
Read more
2023-04-08 (nature.com)
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques
Omicron spike (S) encoding vaccines as boosters, are a potential strategy to improve COVID-19 vaccine efficacy against Omicron. Here, macaques( mostly females) previously immunized with Ad26.COV2.S, are boosted with Ad26.COV2.S, Ad26.COV2.S.529( encoding Omicron BA.1 S) or a 1:1 combination of both
Read more
2022-01-13 (contractpharma.com)
LJI and Charles River Laboratories Launch New COVID-19 Research Project
Agreement paves the way for better mouse models to study how the human immune system fights SARS-CoV-2.
Read more
2022-01-06 (eurekalert.org)
LJI and Charles River Laboratories to collaborate on COVID-19 research
Scientists at La Jolla Institute for Immunology( LJI) and Charles River Laboratories International, Inc., are launching a new project to uncover exactly how different cells in the human immune system respond to SARS-CoV-2, the virus that causes
Read more
2021-08-20 (counton2.com)
Clean needles depend on the blue blood of horseshoe crabs
CHARLESTON, S.C. (AP) — It’s one of the stranger, lesser-known aspects of U.S. health care — the striking, milky-blue blood of horseshoe crabs is a critical component of tests to ensure injectable medications such as coronavirus vaccines aren’t contaminated.
Read more
2021-05-12 (bloomberglaw.com)
Pharma Lab Seeks Emergency Order to Begin Horseshoe Crab Harvest
A lower court’ s block on an upcoming horseshoe crab harvest in a South Carolina refuge would“ impose immeasurable economic and reputational harm” on Charles River Laboratories International Inc. and threaten public health during the Covid-19
Read more